Citigroup Inc Haemonetics Corp Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Citigroup Inc holds 435,617 shares of HAE stock, worth $22.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

435,617

Previous 625,565 30.36%

Holding current value

$22.8 Million

Previous $39.8 Million 18.24%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$56.04 - $74.77 $10.6 Million - $14.2 Million	-189,948 Reduced 30.36%	435,617 $32.5 Million
Q1 2025 May 12, 2025	BUY	$59.34 - $80.05 $17.3 Million - $23.3 Million	291,574 Added 87.3%	625,565 $39.8 Million
Q4 2024 Feb 12, 2025	BUY	$71.16 - $93.38 $9.99 Million - $13.1 Million	140,333 Added 72.46%	333,991 $26.1 Million
Q3 2024 Nov 12, 2024	SELL	$72.45 - $91.58 $2.66 Million - $3.36 Million	-36,717 Reduced 15.94%	193,658 $15.6 Million
Q2 2024 Aug 12, 2024	BUY	$81.24 - $97.37 $12.4 Million - $14.9 Million	152,935 Added 197.49%	230,375 $19.1 Million
Q1 2024 May 10, 2024	SELL	$71.24 - $85.35 $5.18 Million - $6.21 Million	-72,759 Reduced 48.44%	77,440 $6.61 Million
Q4 2023 Feb 09, 2024	SELL	$80.59 - $92.61 $82,927 - $95,295	-1,029 Reduced 0.68%	150,199 $12.8 Million
Q3 2023 Nov 09, 2023	SELL	$82.56 - $93.49 $2.26 Million - $2.56 Million	-27,390 Reduced 15.33%	151,228 $13.5 Million
Q2 2023 Aug 10, 2023	BUY	$80.84 - $89.45 $6 Million - $6.64 Million	74,190 Added 71.04%	178,618 $15.2 Million
Q1 2023 May 11, 2023	SELL	$72.75 - $90.6 $3 Million - $3.74 Million	-41,268 Reduced 28.32%	104,428 $8.64 Million
Q4 2022 Feb 09, 2023	BUY	$73.85 - $86.14 $3.55 Million - $4.14 Million	48,101 Added 49.29%	145,696 $11.5 Million
Q3 2022 Nov 10, 2022	SELL	$63.3 - $78.66 $2.29 Million - $2.84 Million	-36,131 Reduced 27.02%	97,595 $7.23 Million
Q2 2022 Aug 10, 2022	BUY	$49.27 - $66.08 $720,524 - $966,353	14,624 Added 12.28%	133,726 $8.72 Million
Q1 2022 May 12, 2022	BUY	$43.77 - $63.22 $318,251 - $459,672	7,271 Added 6.5%	119,102 $7.53 Million
Q4 2021 Feb 10, 2022	SELL	$49.55 - $74.59 $101,032 - $152,089	-2,039 Reduced 1.79%	111,831 $5.93 Million
Q3 2021 Nov 10, 2021	BUY	$57.6 - $70.59 $6.56 Million - $8.04 Million	113,870 New	113,870 $8.04 Million

Others Institutions Holding HAE

# of Institutions

336

Shares Held

53.3M

Call Options Held

541K

Put Options Held

309K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.68B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account